Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism

Chest. 2004 Sep;126(3):687-92. doi: 10.1378/chest.126.3.687.

Abstract

Study objectives: The aim of this study was to investigate whether risk factors for embolism would promote thrombus formation in patients with nonvalvular atrial fibrillation (NVAF).

Methods: Hemostatic markers for platelet activity (ie, platelet factor-4 and beta-thromboglobulin [TG]), thrombotic status (ie, prothombin fragments 1 and 2), and fibrinolytic status (ie, d-dimer) were determined in 246 patients with NVAF (mean age, 66.1 years) and 111 control subjects without NVAF (68.3 years).

Results: The beta-TG level was higher in NVAF patients than in control subjects. D-dimer levels were higher in NVAF patients having risk factors (mean [+/- SE] d-dimer level, 158.6 +/- 9.2 ng/mL) than in those without risk factors (mean d-dimer level, 92.1 +/- 6.7 ng/mL; p < 0.01) and in control subjects (mean d-dimer level: control subjects with risk factors, 79.1 +/- 10.3 ng/mL; control subjects without risk factors, 31.0 +/- 7.4 ng/mL; p < 0.01). NVAF (odds ratio [OR], 3.94; 95% confidence interval [CI], 1.87 to 8.30; p = 0.0003) and age of >/= 75 years (OR, 5.68; 95% CI, 2.87 to 11.23; p < 0.0001) emerged as predictors of elevated levels of d-dimer, and only NVAF (OR, 10.30; 95% CI, 5.67 to 18.72; p < 0.0001) emerged as a predictor of elevated levels of beta-TG.

Conclusions: NVAF patients whose conditions were complicated with risk factors for embolism could be in the prothrombotic state. Advanced age is a strong predictor of the prothrombotic state in NVAF patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Atrial Fibrillation / blood*
  • Atrial Fibrillation / etiology
  • Embolism / blood*
  • Embolism / diagnosis
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Hemostasis / physiology*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Prothrombin / analysis*
  • Risk Factors
  • Thrombophilia / blood*
  • Thrombophilia / diagnosis
  • beta-Thromboglobulin / analysis

Substances

  • Fibrin Fibrinogen Degradation Products
  • beta-Thromboglobulin
  • fibrin fragment D
  • Prothrombin